Cleared Traditional

K993553 - GTI-FVIII INHIBITOR ASSAY
(FDA 510(k) Clearance)

K993553 · Genetic Testing Institute · Hematology
Feb 2000
Decision
104d
Days
Class 2
Risk

K993553 is an FDA 510(k) clearance for the GTI-FVIII INHIBITOR ASSAY, a Test, Qualitative And Quantitative Factor Deficiency (Class II — Special Controls, product code GGP), submitted by Genetic Testing Institute (Brookfield, US). The FDA issued a Cleared decision on February 1, 2000, 104 days after receiving the submission on October 20, 1999. This device falls under the Hematology review panel. Regulated under 21 CFR 864.7290.

Submission Details

510(k) Number K993553 FDA.gov
FDA Decision Cleared SESE
Date Received October 20, 1999
Decision Date February 01, 2000
Days to Decision 104 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary Summary PDF

Device Classification

Product Code GGP — Test, Qualitative And Quantitative Factor Deficiency
Device Class Class II — Special Controls
CFR Regulation 21 CFR 864.7290

Similar Devices — GGP Test, Qualitative And Quantitative Factor Deficiency

All 189
CRYOcheck Chromogenic Factor VIII
K251440 · Precision Biologic, Inc. · Aug 2025
HemosIL Chromogenic Factor IX
K230852 · Instrumentation Laboratory Company · Dec 2023
vWF Ag
K220728 · Siemens Healthcare Diagnostics Products GmbH · Jun 2023
CRYOcheck Chromogenic Factor IX
K214002 · Precision Biologic, Inc. · Dec 2022
HemosIL von Willebrand Factor Antigen
K223402 · Instrumentation Laboratory CO · Dec 2022
HemosIL von Willebrand Factor Antigen
K200033 · Instrumentation Laboratory CO · Aug 2020